Abstract

Recently the use of biologic materials as dura mater repair patches has been increasing. The purpose of this study is to assess the basis for efficacy and safety of using a novel fish derived acellular dermis (Kerecis Omega3 DuraTM). In an ovine model a craniotomy under general anaesthesia was performed. A defect was produced in the dural covering of approximately 1 × 2 cm and closed with an onlay technique, with Kerecis Omega3 Dura. The bone defect was covered with the bony flap and the overlying tissues closed in layers. At 2, 5, 8 and 11 weeks the sheep underwent MRI scanning followed by euthanasia, necropsy and histological assessment. MRI images taken at 2, 5, 8 and 11 weeks showed initially moderate inflammatory response, which diminished over time, and at 11 weeks no evidence of inflammation existed. There was evidence of cerebrospinal fluid leakage at no time point. Necropsy revealed some adhesions at 5 and 8 weeks, in particular at 5 weeks, but at 11 weeks there were no adhesions found. From 2 - 11 weeks, there was evidence of initially an inflammatory reaction followed by neodura formation at the defect site through cellular ingrowth and remodeling of the acellular fish skin. Histology showed a histiocytic foreign body reaction initially that subsided over time. As early as 8 weeks there was evidence of neodura formation and by 11 weeks there was a minimal inflammatory response with an intact neodura formed. In this pilot study the Kerecis Omega3 Dura patches performed in a safe and efficacious manner. This new material needs to be fully assessed and compared with other products that are currently on the market in a larger scale animal study.

Highlights

  • All commercially available tissue based or tissue derived materials used for implantation to date are derived from mammalian sources

  • As no disease transmission risk exists in the use of fish skin, fats are not washed away during processing and the materials are referred to as acellular fish skin

  • Biologic products have been assessed in a variety of neurosurgical procedures, proving to be safe and effective. An example of such an assessment is a study with an onlay suture-free technique, where the results demonstrated that operating theatre time was minimized and that no secondary cerebrospinal fluid (CSF) leaks were observed [2]-[6]

Read more

Summary

Introduction

All commercially available tissue based or tissue derived materials used for implantation to date are derived from mammalian sources. Biologic tissue based materials are normally referred to as Acellular Dermal Matrices (ADM’s) and Extra Cellular Matrices (ECM’s). Biologic tissue derived materials are normally referred to as collagen scaffolds. Tissue based materials are intact tissues where cells and fats have been washed away with detergents because of disease transmission risk. As no disease transmission risk exists in the use of fish skin, fats are not washed away during processing and the materials are referred to as acellular fish skin. Tissue derived materials are denatured protein polymers (normally collagen) that have been extracted from tissue through hydrolysis

Objectives
Methods
Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call